TP53 and pancreatic adenocarcinoma: The TP53 gene is the most frequently mutated gene identified in human cancer (Soussi and Lozano, 2005) and a 50–70% mutation rate was reported in pancreatic adenocarcinoma, ranking this disease among those with the highest incidence of TP53 inactivation (Rozenblum et al, 1997).